Back to the main directory
EarningsReview / Equity
- Itaú BBA on Credicorp: 4Q19 Earnings Miss on Soft NII and Higher Expenses by Itau
- Q320 trading and 15 questions for management by BNP Paribas
- Advanced Info Service (ADVANC TB) by HSBC
- Verisec Freja eID launch – worth the wait by DnB Markets
- NTT (9432 JP) by HSBC
- Q4: Entering the final straight by BNP Paribas
- Solar - Market slowdown should also hit Solar by Danske Bank Equity Research
- Vinci (DG FP) by HSBC
- Mycronic - Expect a slow H1 20, but long-term drivers intact by Danske Bank Equity Research
- Itaú BBA on ABC Brasil: Neutral 4Q19, Guidance for 2020 and 2021 Announced by Itau
- BioGaia - Case confirmed by Danske Bank Equity Research
- Sampo - Heading to an underwriting sweet spot in 2020 by Danske Bank Equity Research
- Fortum - Low Nordic power prices weigh on earnings outlook by Danske Bank Equity Research
- Spar Nord - Uninspiring 2022 plan a negative game changer by Danske Bank Equity Research
- Lundbeck - 2020: key is to execute on Eptinezumab by Danske Bank Equity Research
- Capital optics by BNP Paribas
- ICA Gruppen - Adaptation and transformation cost picking up by Danske Bank Equity Research
- Orkla (Sell, TP: NOK77.00) - Mixed report by DnB Markets
- Coloplast (Sell, TP: DKK700.00) - Strong Ostomy organic growth by DnB Markets
- Veoneer (Buy, TP: SEK240.00) - Reassuring on 2020 inflection by DnB Markets
- Fabege (Buy, TP: SEK181.00) - The maiden deal in Flemingsberg by DnB Markets
- Axactor (Buy, TP: NOK27.00) - Equity issue and preliminary Q4 by DnB Markets
- Aker Solutions (Buy, TP: NOK26.00) - No triggers in sight by DnB Markets
- Borregaard (Hold, TP: NOK105.00) - Set for improved 2020 by DnB Markets
- Vestas Wind Systems (Hold, TP: DKK750.00) - 2020 guidance disappoints by DnB Markets
- Yum China Holdings Inc (YUMCÂ US) by HSBC
- DFDS - Short-term hiccups in strong investment case by Danske Bank Equity Research
- Focus points for Q4 results by BNP Paribas
- Progress continues by BNP Paribas
- Korea Shipbuilding by HSBC
- Signs of stabilisation? by BNP Paribas
- Axfood - Outperformance is narrowing as competition heats up by Danske Bank Equity Research
- Vitrolife - More clouds on the horizon by Danske Bank Equity Research
- Itaú BBA on Klabin: Positive 4Q19 Results on Strong Cost Performance by Itau
- Gujarat Pipavav Ports (GPPV IN) by HSBC
- Sampo - Heading to an underwriting sweet spot in 2020 by Danske Bank Equity Research
- Satellite operators to earn cUSD10bn in C-band by BNP Paribas
- Nordea - In Frank we trust by Danske Bank Equity Research
- Midsona - Messy quarter by Danske Bank Equity Research
- Equinor - Higher capex post 2021 suggests a lower yield by Danske Bank Equity Research
- DNO - Higher costs and impairment hit Q4, strong cash flow by Danske Bank Equity Research
- DNB - Stellar 2019 as expected, now the real test starts by Danske Bank Equity Research
- Lundbeck (Buy, TP: DKK310.00) - Organic growth to return in 2020e by DnB Markets
- Novo Nordisk (Buy, TP: DKK480.00) - Room for more in 2020e by DnB Markets
- Hexagon AB (Hold, TP: SEK575.00) - Recovery priced in by DnB Markets
- Valmet (Buy, TP: EUR27.00) - From strength to strength by DnB Markets
- Maersk Drilling (Buy, TP: DKK600.00) - Unique, but conservative by DnB Markets
- ALK-Abello (Hold, TP: DKK2050.00) - Strong underlying growth outlook by DnB Markets
- Nordea (Buy, TP: SEK92.00) - On track for 10% ROE target by DnB Markets
- Sampo Oyj (Buy, TP: EUR46.00) - Improvements in Nordea by DnB Markets